AbbVie
ABBV
1,798 hedge funds and large institutions have $99.5B invested in AbbVie in 2017 Q3 according to their latest regulatory filings, with 123 funds opening new positions, 596 increasing their positions, 824 reducing their positions, and 68 closing their positions.
81% more first-time investments, than exits
New positions opened: 123 | Existing positions closed: 68
36% more funds holding in top 10
Funds holding in top 10: 118 → 160 (+42)
24% more capital invested
Capital invested by funds: $80.1B → $99.5B (+$19.4B)
17% more call options, than puts
Call options by funds: $1.25B | Put options by funds: $1.07B
2% more funds holding
Funds holding: 1,763 → 1,798 (+35)
0.86% more ownership
Funds ownership: 69.41% → 70.28% (+0.86%)
28% less repeat investments, than reductions
Existing positions increased: 596 | Existing positions reduced: 824
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$896M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$818M |
| 3 |
Jennison Associates
New York
|
+$466M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$346M |
| 5 |
BlackRock
New York
|
+$345M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIM
Woodford Investment Management
London,
United Kingdom
|
-$607M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$342M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$267M |
| 4 |
State Street
Boston,
Massachusetts
|
-$240M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$186M |
ABBV Hedge Fund Activity: Q3 2017 in Review
1,798 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q3 2017, worth a combined $99.5B — up 24% from $80.1B a quarter earlier.
Buyers outnumbered sellers: 123 funds opened new ABBV positions and 68 closed out — a net gain of 55 holders — while 596 added to existing stakes and 824 trimmed.
The largest buyer was Capital World Investors, adding an estimated $896M. The largest seller was Woodford Investment Management, cutting an estimated $607M.
- 1,798 institutional investors held AbbVie (ABBV) as of Q3 2017, up from 1,763 in Q2 2017.
- Funds reported $99.5B of AbbVie stock for Q3 2017, up 24% quarter-over-quarter.
- 123 funds opened new AbbVie positions in Q3 2017 and 68 closed out, a net change of +55 holders.
- The largest AbbVie buyer in Q3 2017 was Capital World Investors, an estimated $896M added.
- The largest AbbVie seller in Q3 2017 was Woodford Investment Management, an estimated $607M sold.
Based on aggregated 13F filings for Q3 2017.